Please assess the completion status of the following clinical trial:

Trial Title: Metoclopramide for Post Traumatic Headache

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Included patients will be adults who meet International Classification of Headache Disorders criteria for acute post-traumatic headache. These are as follows:~* Traumatic injury to the head has occurred~* Headache has developed within 7 days of injury to the head~* Headache is not better accounted for by another diagnosis (eg, previous history of migraine or tension-type headache)~The headache must be rated as moderate or severe in intensity at the time of initial evaluation.~Exclusion Criteria:~Patients will be excluded if more than ten days have elapsed since the head trauma, if the headache has already been treated with an anti-dopaminergic medication, or for medication contra-indications including pheochromocytoma, seizure disorder, Parkinson's disease, use of MAO inhibitors, and use of anti-rejection transplant medications.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Metoclopramide (Type: EXPERIMENTAL): Metoclopramide 20mg + diphenhydramine 25mg + 100cc normal saline, administered as an intravenous drip
- Placebo (Type: PLACEBO_COMPARATOR): Normal saline, administered as an intravenous drip

Based on this trial design, predict the completion outcome and termination type (if applicable).